Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal

Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal

Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition. Development of acute abdominal pain after Kayexala...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical case reports 2020-04, Vol.8 (4), p.722-724
Hauptverfasser: Singhania, Namrata, Al‐Odat, Raman, Singh, Anil K., Al‐Rabadi, Laith
Format: Artikel
Sprache:eng
Schlagworte:
Abdomen
activated charcoal
Blood pressure
Case Report
Case Reports
Charcoal
Drug overdose
end‐stage renal disease
intentional drug overdose
kayexalate
Kidney diseases
kidney transplant
Kidney transplants
Lavage
Necrosis
Patients
Potassium
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition. Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.2695